Personal CFO Solutions LLC bought a new position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,046 shares of the company's stock, valued at approximately $285,000.
Other large investors have also added to or reduced their stakes in the company. Westend Capital Management LLC lifted its stake in Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after acquiring an additional 140 shares during the last quarter. Vermillion Wealth Management Inc. acquired a new stake in Colgate-Palmolive in the fourth quarter valued at $31,000. Wintrust Investments LLC acquired a new stake in Colgate-Palmolive in the fourth quarter valued at $33,000. Accredited Wealth Management LLC acquired a new stake in Colgate-Palmolive in the fourth quarter valued at $34,000. Finally, Bernard Wealth Management Corp. acquired a new stake in Colgate-Palmolive in the fourth quarter valued at $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have commented on CL shares. Piper Sandler cut their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research note on Monday, March 31st. Barclays cut their price target on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research note on Friday, April 11th. Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. UBS Group lifted their target price on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. Finally, Citigroup lifted their target price on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of "Hold" and a consensus price target of $101.69.
Read Our Latest Research Report on Colgate-Palmolive
Colgate-Palmolive Stock Performance
Colgate-Palmolive stock traded down $0.95 during midday trading on Thursday, hitting $90.63. The company's stock had a trading volume of 4,531,922 shares, compared to its average volume of 4,838,729. Colgate-Palmolive Company has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 8.96, a current ratio of 0.85 and a quick ratio of 0.54. The company has a 50-day moving average price of $90.65 and a two-hundred day moving average price of $90.55. The company has a market cap of $73.45 billion, a price-to-earnings ratio of 25.60, a PEG ratio of 4.89 and a beta of 0.37.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.86 by $0.05. The company had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The business's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.86 EPS. As a group, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.30%. The ex-dividend date of this dividend is Friday, July 18th. Colgate-Palmolive's payout ratio is presently 58.76%.
Colgate-Palmolive declared that its Board of Directors has approved a stock repurchase plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to purchase up to 6.8% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's management believes its shares are undervalued.
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.